Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Abstracts of Oral PapersSession 2: Infectious Diseases

Abstracts of Oral PapersSession 2: Infectious Diseases SESSION 2 : INFECTIOUS DISEASES Human hyperimmune IgG from immunized. plasma donors for treatment and prevention of infection with multi-drug resistant Staphylococcus aureus A. Fattom. L. Basham, S. Shepherd, J. Sarwar, A Ortioz, L. Fries, and R Naso W. W.Karakawa Bacterial Pathogenesis Laboratory. NABL Rockville. MD. USA The emergence and rapid spread in hospitals of multidrug resistant bacterial infections such as vancomycin resistant enterococci, methicillin resistant staphylococci and penicillin resistant pneumococci, have drawn attention to the need for alternative therapies, including immunotherapies, to combat these. Capsular polysaccharide (CP) vaccines were developed and proved to be effective in preventing some bacterial infections including pneumococci and meningococci. However, active immunization of several at-risk populations is impractical. Active immunization requires both immuno competance and a window of time, from a few days to a few weeks, for the body to mount an appropriate immune response. Groups such as trauma patients, low birthweight neonates, patients on chemotherapy; and many surgical patients are at high risk for infection and either have compromised immune systems, or do not have enough time to mount an effective immune response to active immunization before the onset of infection. For these indiciduals, passive immunization in the form of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Human Antibodies IOS Press

Abstracts of Oral PapersSession 2: Infectious Diseases

Human Antibodies , Volume 7 (2) – Jan 1, 1996

Loading next page...
 
/lp/ios-press/abstracts-of-oral-paperssession-2-infectious-diseases-x66UdCallp

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
IOS Press
Copyright
Copyright © 1996 by IOS Press, Inc
ISSN
1093-2607
eISSN
1875-869X
DOI
10.3233/HAB-1996-7203
Publisher site
See Article on Publisher Site

Abstract

SESSION 2 : INFECTIOUS DISEASES Human hyperimmune IgG from immunized. plasma donors for treatment and prevention of infection with multi-drug resistant Staphylococcus aureus A. Fattom. L. Basham, S. Shepherd, J. Sarwar, A Ortioz, L. Fries, and R Naso W. W.Karakawa Bacterial Pathogenesis Laboratory. NABL Rockville. MD. USA The emergence and rapid spread in hospitals of multidrug resistant bacterial infections such as vancomycin resistant enterococci, methicillin resistant staphylococci and penicillin resistant pneumococci, have drawn attention to the need for alternative therapies, including immunotherapies, to combat these. Capsular polysaccharide (CP) vaccines were developed and proved to be effective in preventing some bacterial infections including pneumococci and meningococci. However, active immunization of several at-risk populations is impractical. Active immunization requires both immuno competance and a window of time, from a few days to a few weeks, for the body to mount an appropriate immune response. Groups such as trauma patients, low birthweight neonates, patients on chemotherapy; and many surgical patients are at high risk for infection and either have compromised immune systems, or do not have enough time to mount an effective immune response to active immunization before the onset of infection. For these indiciduals, passive immunization in the form of

Journal

Human AntibodiesIOS Press

Published: Jan 1, 1996

There are no references for this article.